Rankings
▼
Calendar
AMRN FY 2023 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$310M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$307M
-16.9% YoY
Gross Profit
$166M
53.9% margin
Operating Income
-$68M
-22.0% margin
Net Income
-$59M
-19.3% margin
EPS (Diluted)
$-3.00
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
$7M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$832M
Total Liabilities
$280M
Stockholders' Equity
$552M
Cash & Equivalents
$199M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$307M
$369M
-16.9%
Gross Profit
$166M
$242M
-31.7%
Operating Income
-$68M
-$106M
+36.2%
Net Income
-$59M
-$106M
+44.1%
← Q4 2022
All Quarters
Q1 2023 →